REGIONAL- While a federal vaccine advisory panel last week narrowed its COVID-19 recommendations and even flirted with requiring prescriptions, Minnesota health officials announced Monday they’ll chart their own path, one focused on keeping vaccines widely available.
The split was striking. On Friday, the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) pulled back from its years-long approach of encouraging routine vaccination for nearly all age groups. Three days later, the Minnesota Department of Health said it will instead rely on professional medical associations — a step many other states are also taking — that continue to recommend broad access.
CDC confusion
The ACIP meeting itself was tumultuous, with technical glitches, sharp disagreements, and plenty of uncertainty about what the recommendations actually mean for patients. What came out of it was the message that routine vaccination is no longer the baseline.
Instead, the panel voted to recommend shots primarily for adults 65 and older and for younger people under a process called “shared clinical decision-making.” In other words, anyone over six months old can still get the vaccine, but for people under 65, the expectation is to have a conversation with a clinician about whether it makes sense for them.
Jen Kates, director of global health and HIV policy at the health policy organization KFF, told NPR news the shift is significant.
“In the prior seasons of COVID, we’ve had routine vaccine access – you or I could go to our pharmacy or doctor’s office and just get our vaccine, it was encouraged as a routine recommendation,” she said. Friday’s vote “essentially says this is no longer routinely recommended. It’s ‘shared clinical decision-making,’” she added.
The panel also voted to expand language about possible risks and uncertainties onto vaccine information sheets, even though many of the debated risks were speculative or already ruled out, further fueling concern that public confidence in the vaccines could take a hit.
No prescription required
Perhaps the most contentious idea on the table was a proposal to require prescriptions for anyone seeking a COVID-19 vaccine. Critics warned such a move would pile on barriers, especially for the millions of Americans who don’t have a regular doctor.
Opponents argued it would overwhelm physicians’ offices and cut vaccination rates. The proposal ended in a tie but was ultimately defeated when ACIP Chairman Martin Kulldorff cast the deciding no vote.
Even so, the fight rattled observers. Dr. Sandra Fryhofer, speaking for the American Medical Association, said the process showed an “erosion of the committee’s integrity,” with data being “selectively used to justify specific conclusions.”
For many in the medical community, the episode raised doubts about whether the panel is still playing by the science-based rules it once did.
Minnesota takes its own course
Minnesota’s move had been widely expected and was swift in coming. On Monday, MDH announced it is backing recommendations from national medical associations, including the American Academy of Pediatrics, the American Academy of Family Physicians, and the American College of Obstetricians and Gynecologists, that continue to call for broad access to vaccination.
Those groups say everyone over six months should have the easily accessible option to be vaccinated, period. Unlike the federal panel, which put younger and healthier adults into a “talk it over with your doctor” category, the associations make vaccination broadly available while placing extra emphasis on children under two, pregnant women, people with high-risk conditions, and adults 65 and older.
“We’re following the science, and the science is clear. COVID-19 vaccines prevent severe illness and death for people of all ages, and we want to ensure access to vaccination,” said Minnesota Health Commissioner Brooke Cunningham. She added that federal guidance now leaves “important information gaps for Minnesotans.”
Ruth Lynfield, MDH’s medical director and state epidemiologist, emphasized the effectiveness of vaccines.
“Vaccines are one of the greatest public health achievements in modern medicine and help protect people of all ages,” she said.
She noted that this fall isn’t just about COVID-19 – flu, RSV, and COVID vaccines together form a key line of defense as the state heads into respiratory disease season.
Walz sets the stage
Minnesota’s stance didn’t come out of the blue. Earlier this month, Gov. Tim Walz signed an executive order directing MDH to take steps to safeguard vaccine access as the federal process grew more uncertain.
“While the Trump Administration attempts to limit Americans’ access to preventative care, Minnesota will be guided by science and medical expertise, prioritizing the health and safety of our people,” Walz said at the time.
The order called for MDH to issue a standing order for COVID-19 vaccines, a step the department confirmed it has now taken. That move empowers pharmacists to provide shots without requiring a doctor’s prescription, keeping access closer to the “walk in and get one” model Minnesotans are used to.
Access and affordability
State officials also acknowledged concerns about how federal shifts could affect insurance coverage. Walz’s order directed MDH and the Minnesota Department of Commerce to work with insurers, providers, and medical associations to ensure coverage continues. Those conversations are expected to happen before the end of September.
Meanwhile, MDH stressed that Minnesota still operates programs that provide certain vaccines at low or no cost to children and adults who are uninsured or underinsured. Pharmacists in the state can vaccinate children as young as 3, though pediatric doses may take longer to arrive in pharmacies and clinics.
New COVID-19 vaccines are already shipping to pharmacies and clinics across Minnesota, with availability expected to grow in the weeks ahead. Health officials are urging people to call ahead to their desired source for vaccination to confirm supply and to check with their insurance provider if they have questions about coverage.